Simple Summary B-cell Acute Lymphoblastic Leukaemia is one of the most common cancers
in childhood, with 20% of patients eventually relapsing. Flow cytometry is routinely used for …

Introduction Loss of B-cell aplasia (BCA) is a well-known marker of functional loss of CD19
CAR-T. Most relapses and loss of BCA occur in the first months after CD19 CAR-T infusion. In …

Haematopoiesis is the process of generation of blood cells. Lymphopoiesis generates
lymphocytes, the cells in charge of the adaptive immune response. Disruptions of this process are …

Although children and adolescents with acute lymphoblastic leukaemia (ALL) have high
survival rates, approximately 15-20% of patients relapse. Risk of relapse is routinely estimated …

Frontiers | Corrigendum: Impact of disease burden and late loss of B cell aplasia on the risk
of relapse after CD19 chimeric antigen receptor T Cell (Tisagenlecleucel) infusion in …

Background A new clinical syndrome named Paediatric Inflammatory Multisystem Syndrome
Temporally Associated with SARS-CoV-2 (PIMS-TS) has been described. This new disease …

Los tratamientos inmunosupresores propuestos para actuar sobre la progresión de la
enfermedad 1, se prescribieron en el 48% de los pacientes, con un uso mayoritario de corticoides…

Aim The immune status of children recovering from SARS‐CoV‐2 infection is not completely
understood. We describe IgG antispike persistence in children infected during the first two …

Aim To determine the prevalence and magnitude of medication errors and their association
with patients' sociodemographic and clinical characteristics and nurses' work conditions. …

Purpose To compare pain incidence and changes in pain scores with fentanyl versus
placebo as pre-emptive treatment during turning and 30 min post-turning in mechanically …